Cat. No.: DIA-0243295
Product Information | |
---|---|
CAS No. | 168158-16-5 |
Formula | C18H27N3O4 |
Molecular Weight | 349.42 |
SMILES | ONC([C@@H](C)[C@@H](CC(C)C)C(N[C@@H](C1=CC=CC=C1)C(NC)=O)=O)=O |
Target | MMP |
Product Description | KB-R7785 is a novel matrix metalloproteinase (MMP) inhibitor, which improves insulin sensitivity by inhibiting TNF-α production. KB-R7785 can be used for diabetes research. KB-R7785 has a protective efficacy against focal cerebral ischemia. |
Format & Storage | |
---|---|
Shipping | Room temperature in the continental U.S. Other areas may vary. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.